She manages a team of consultants supporting clients in Hong Kong, China, and other Asia-Pacific markets, and complementing Boston Healthcare’s global reimbursement and market access advisory services.
Ms. Su specializes in market access and regulatory strategy in China, advising drug, device, and diagnostics companies on commercialization and business development opportunities. She advises biopharmaceutical, medical device, imaging and diagnostics companies in the areas of pricing and reimbursement, sales and marketing, market development, and growth strategy. Prior to her consulting role, Ms. Su held several positions at AstraZeneca in China in marketing, government affairs, and corporate communications.
Ms. Su completed her international MBA degree through a joint program between the Norwegian School of Management and Fudan University in 2007 and has a bachelor’s degree in international marketing from the Shanghai Institute of Foreign Trade.